期刊文献+

顺铂+5-氟脲嘧啶介入化疗晚期宫颈癌35例疗效 被引量:2

Efficacy of cisplatin and 5-fluorouracil chemotherapy on locally advanced cervical cancer intervention program in 35 cases
在线阅读 下载PDF
导出
摘要 目的观察超选择动脉插管+顺铂联合5-氟脲嘧啶方案化疗在局部肿块直径≥4 cm的Ⅱa一Ⅲb期宫颈癌治疗中的疗效。方法分析35例肿瘤直径≥4cm的Ⅱa一Ⅲb期宫颈癌患者根治术前给予子宫动脉灌注化疗,观察肿块缩小程度、后续治疗及随访情况。结果完全缓解22例,部分缓解10例,总有效率91.4%,手术成功率81.3%;介入化疗后手术再辅以放化疗患者中位生存期15(6—38)个月;介入化疗后再行放化疗患者中位生存期12(3~38)个月。结论超选择动脉插管+顺铂联合5-氟脲嘧啶方案化疗作为术前辅助化疗对局部晚期宫颈癌患者是安全有效的。 Objective To investigate the efficacy of cisplatin and 5-fluorouracil with super-selective arterial cannulation in chemotherapy of cervical cancer with local tumor diameter ≥ 4cm at stage II a-lllb. Methods 35 cases of cervical cancer with tumor diameter≥4cm at stage Ⅱ a-Ⅲ b received uterine artery infusion chemotherapy before radical surgery to observe the diminished extent of tumor, successive treatment and follow-up. Results Complete remission was achieved in 22 cases, and partial remission in 10 cases. The total effective rate was 91.4% and the success rate of operation was 81.3%. The median survival time of cases operated and assisted with chemotherapy after interventional chemotherapy was 15 months (6-38 months), and that of those only receiving chemotherapy after interventional chemotherapy was 12 months (3-38 months). Conclusion Super-selective arterial and cisplatin and 5-fluorouracil regimen is safe and effective as preoperative chemotherapy for locally advanced cervical cancer patients.
出处 《中国妇幼健康研究》 2011年第4期537-539,共3页 Chinese Journal of Woman and Child Health Research
关键词 超选择性动脉插管 宫颈癌 血管造影 化疗 super-selective arterial cannulation cervical cancer angiography chemotherapy
  • 相关文献

参考文献8

二级参考文献50

  • 1吴小华,李子庭,黄啸,周瑜琪,程玺,蔡树模,张志毅.放疗对早期子宫颈癌患者移位卵巢功能的影响[J].中华妇产科杂志,2005,40(4):220-222. 被引量:34
  • 2Berek JS,Hacker NF.Practical gynecologic oncology[M].4 th ed.Lippincott:Williams & Wilkins,2004:119-162.
  • 3沈铿 郎景和.妇科肿瘤面临的问题和挑战[M].北京:科学出版社,2003.249.
  • 4Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin,1999,49:33-64.
  • 5Minagawa Y, Kigawa J, Irie T, et al. Radical surgery following neoadjuvant chemotherapy for patients with stage ⅢB cervical cancer.Ann Surg Oncol,1998,5:539-543.
  • 6Ivanov S, Zervudis S, Ivanov S. Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage Ⅰ B and Ⅱ A cervical cancer.Akush Ginekol (Sofiia),2003,42:22-24.
  • 7Toita T, Mitsuhashi N, Teshima T, et al.Postoperative radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.Jpn J Clin Oncol,2004,34:99-103.
  • 8Frei E 3rd. Clinical cancer research: an embattled species. Cancer,1982, 50:1979-1992.
  • 9Hwang YY, Moon H, Cho SH, et al. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol,2001, 82:88-93.
  • 10Aoki Y, Sasaki M, Watanabe M, et al. High-risk group in node-positive patients with stage ⅠB, ⅡA, and ⅡB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol,2000, 77:305-309.

共引文献111

同被引文献8

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部